DNA homologous recombination factor SFR1 physically and functionally interacts with estrogen receptor alpha.

Estrogen receptor alpha (ER?), a ligand-dependent transcription factor, mediates the expression of its target genes by interacting with corepressors and coactivators. Since the first cloning of SRC1, more than 280 nuclear receptor cofactors have been identified, which orchestrate target gene transcription. Aberrant activity of ER or its accessory proteins results ...
in a number of diseases including breast cancer. Here we identified SFR1, a protein involved in DNA homologous recombination, as a novel binding partner of ER?. Initially isolated in a yeast two-hybrid screen, the interaction of SFR1 and ER? was confirmed in vivo by immunoprecipitation and mammalian one-hybrid assays. SFR1 co-localized with ER? in the nucleus, potentiated ER's ligand-dependent and ligand-independent transcriptional activity, and occupied the ER binding sites of its target gene promoters. Knockdown of SFR1 diminished ER's transcriptional activity. Manipulating SFR1 expression by knockdown and overexpression revealed a role for SFR1 in ER-dependent and -independent cancer cell proliferation. SFR1 differs from SRC1 by the lack of an intrinsic activation function. Taken together, we propose that SFR1 is a novel transcriptional modulator for ER? and a potential target in breast cancer therapy.
Mesh Terms:
Breast Neoplasms, Carrier Proteins, Cell Line, Tumor, Cell Nucleus, Cell Proliferation, Endometrial Neoplasms, Estrogen Receptor alpha, Female, Gene Expression, Gene Expression Regulation, Homologous Recombination, Humans, Nuclear Proteins, Protein Binding, Protein Transport, RNA, Messenger, Transcription Factors, Transcriptional Activation, Two-Hybrid System Techniques
Date: Jul. 23, 2013
Download Curated Data For This Publication
Switch View:
  • Interactions 5